In a regulatory filing, Dolby (DLB) Laboratories senior VP of Entertainment John Couling disclosed the sale of 7,273 class A common shares of the company on December 11 at a price of $68.75 per share, or a total consideration of $500,019.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DLB:
- Strategic Diversification and Innovation Drive Dolby Laboratories’ Growth Potential: A Buy Rating by Ralph Schackart
- Dolby Laboratories Navigates Complex Tech Standards Amid Shifting Broadcast and Internet Landscapes
- Dolby Laboratories Earnings Call: Growth Amid Challenges
- Dolby price target lowered to $85 from $95 at Rosenblatt
- Dolby price target lowered to $95 from $100 at Barrington